NSE: GLENMARK | BSE: 532296 | INDUSTRY : PHARMACEUTICALS | SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY

Glenmark Pharmaceuticals Ltd.

Mid-range Performer

497.95 -31.70 (-5.99%)

96.82% Gain from 52W Low

Volume NSE+BSE : 5.3M

NSEApr 12, 2021 03:31 PM

Check Buy or Sell

Watchlist

Portfolio

Alert

Share

Durability & Valuation Scores
Free SIGN IN to see details
Durability score
65/100
High Financial Strength
Valuation score
41.3/100
Mid Valuation
Momentum score
59.2/100
Technically Neutral
6S
3W
7O
1T



Loading Fundamental data..




News

Is Glenmark Pharmaceuticals Ltd. worth buying?
Total Votes: 413
BUY
SELL
HOLD
78.21%
13.56%
8.23%
  • Stock Price (507.65) crossed above 50 Day SMA (480.26) on 06 April, 2021
  • Stock Price (507.65) crossed above 150 Day SMA (488.47) on 06 April, 2021
  • Stock Price (507.65) crossed above 100 Day SMA (490.7) on 06 April, 2021
  • Stock Price (507.65) crossed above 200 Day SMA (479.18) on 06 April, 2021
  • Stock Price (483.25) crossed above 30 Day SMA (470.5) on 01 April, 2021
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 17, 20202.50FINAL-
Sept. 19, 20192.00FINAL-
Sept. 19, 20182.00FINAL-
Sept. 20, 20172.00FINAL-
Aug. 3, 20162.00FINAL-
All dividends by GLENMARK
Ex-Date Dividend Bonus Ratio Record Date
March 4, 20051:1-
All bonuses by GLENMARK
Ex-Date Dividend Old FVNew FV Record Date
Sept. 10, 200721-
Oct. 23, 2003102Oct. 31, 2003
All splits by GLENMARK